accountproducts. Maisonrouge cited the different tactics used in the insulin business taken by Novo Nordisk (NOVOb.CO) and Eli Lilly and Co (LLY.N), suggesting that Novo Nordisk's broader approach was more effective. "Novo was focused on the patient, the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Novel M&A paths gaining acceptance
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account